Medical Supplies & Consumables · Wound Care
Convatec revenue, results and funding
Convatec filed revenue of $2.4B for 2025.
Data updated Nov 20, 2026 · Back to the company report
$2.4BRevenue, 2025
$175MNet income, 2025
London Stock Exchange
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_DIVIDENDS | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $2.4B | $175M | $3.8B | $55M | $140M | $326M | $111M | $316M | $68M | $1.4B | −$1M |
| 2024 | $2.3B | $191M | $3.5B | $55M | $130M | $11M | $112M | $325M | $65M | $1.1B | $14M |
| 2023 | $2.1B | $130.3M | $3.7B | $37.1M | $110.7M | $0 | $110M | $262.7M | $98M | $1.2B | $84.4M |
| 2022 | – | – | – | – | – | – | – | – | $143.8M | – | – |
Sources: ESEF
Rounds and grants
| Year | Round | Amount |
|---|---|---|
| 2023 | Venture | not stated |
| 2023 | Venture | not stated |
| 2022 | Venture | not stated |
| 2021 | Venture | not stated |
| 2021 | Venture | not stated |
| 2020 | Venture | not stated |
| 2020 | Venture | not stated |
| 2019 | Venture | not stated |
| 2019 | Venture | not stated |
| 2018 | Venture | not stated |
| 2018 | Venture | not stated |
| 2017 | Venture | not stated |
| 2016 | Venture | not stated |
Sources: funding announcements, SEC filings, grant registers
How to cite
Convatec, Financials. Alion, Nov 20, 2026. https://alion.io/company/convatec-com/financials
